1. Home
  2. TLS vs NKTX Comparison

TLS vs NKTX Comparison

Compare TLS & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLS
  • NKTX
  • Stock Information
  • Founded
  • TLS 1969
  • NKTX 2015
  • Country
  • TLS United States
  • NKTX United States
  • Employees
  • TLS N/A
  • NKTX N/A
  • Industry
  • TLS EDP Services
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TLS Technology
  • NKTX Health Care
  • Exchange
  • TLS Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • TLS 238.1M
  • NKTX 225.1M
  • IPO Year
  • TLS 2020
  • NKTX 2020
  • Fundamental
  • Price
  • TLS $3.50
  • NKTX $2.38
  • Analyst Decision
  • TLS Buy
  • NKTX Strong Buy
  • Analyst Count
  • TLS 6
  • NKTX 5
  • Target Price
  • TLS $4.80
  • NKTX $15.20
  • AVG Volume (30 Days)
  • TLS 454.9K
  • NKTX 2.3M
  • Earning Date
  • TLS 11-12-2024
  • NKTX 11-07-2024
  • Dividend Yield
  • TLS N/A
  • NKTX N/A
  • EPS Growth
  • TLS N/A
  • NKTX N/A
  • EPS
  • TLS N/A
  • NKTX N/A
  • Revenue
  • TLS $122,959,000.00
  • NKTX N/A
  • Revenue This Year
  • TLS N/A
  • NKTX N/A
  • Revenue Next Year
  • TLS $38.31
  • NKTX N/A
  • P/E Ratio
  • TLS N/A
  • NKTX N/A
  • Revenue Growth
  • TLS N/A
  • NKTX N/A
  • 52 Week Low
  • TLS $1.89
  • NKTX $2.08
  • 52 Week High
  • TLS $5.03
  • NKTX $16.24
  • Technical
  • Relative Strength Index (RSI)
  • TLS 49.00
  • NKTX 35.48
  • Support Level
  • TLS $3.38
  • NKTX $2.08
  • Resistance Level
  • TLS $3.91
  • NKTX $2.39
  • Average True Range (ATR)
  • TLS 0.22
  • NKTX 0.22
  • MACD
  • TLS 0.01
  • NKTX 0.00
  • Stochastic Oscillator
  • TLS 37.88
  • NKTX 16.28

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

Share on Social Networks: